öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

ÕÅ ¾Õ£¬½ÌÊÚ£¬Ë¶Ê¿Ñо¿Éúµ¼Ê¦¡£1965Äê5ÔÂÉú¡£1986Äê»ñµÚËľüÒ½´óѧҽѧѧʿѧ룬1992Äê»ñµÚËľüÒ½´óѧÁÙ´²·Ö×ÓÉúÎïѧ˶ʿѧ룬1998Äê»ñµÚËľüÒ½´óѧÉúÎﻯѧÓë·Ö×ÓÉúÎïѧ²©Ê¿Ñ§Î»¡£2010ÄêÈεÚËľüÒ½´óѧҩѧϵȫ¾ü»ùÒòÕï¶ÏÑо¿Ëù½ÌÊÚ¡£µ£ÈÎÉÂÎ÷Ê¡ÉúÎïоƬ¼¼ÊõöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»áίԱ£¬ÉÂÎ÷Ê¡»ùÒò¼ì²âÖÊÁ¿¿ØÖÆÖÐÐÄר¼ÒίԱ»áίԱ¼°µÚËľüÒ½´óѧѧ±¨Éó¸åר¼Ò¡£

Ñо¿·½Ïò£º

1£®Ó«¹âÆ«Õñ¼ì²â¼¼Êõƽ̨½¨Éè¡¢¸ÄÁ¼ÓëÓ¦ÓãºÓ«¹âÆ«Õñ£¨FP£©¼ì²â¼¼ÊõÊÇÒ»ÖÖÓ«¹â±ê¼Ç¼ì²â¼¼Êõ£¬Ëü°ÑÓ«¹âÎïÖʱê¼ÇÔÚÌض¨ÎïÖÊ·Ö×Ó£¬Ê¹Ô­±¾Î¢ÈõµÄ·´Ó¦ÐźÅת»¯³É½ÏÇ¿µÄÓ«¹âÐźÅ£¬Í¬Ê±ÔڹⷵĺÏÊÊλÖ÷ֱð¼ÓÉÏÆðÆ«Æ÷ºÍ¼ìÆ«Æ÷¾Í¿É²â³ö´ý²âÎïµÄÆ«ÕñÓ«¹âÇ¿¶È£¬´ó´óÌá¸ßÁË·½·¨µÄÁéÃô¶È£¬ÌØÒìÐÔ¡£ÔÚ·ÖÎö·Ö×Ó½áºÏµÄ·½·¨ÖУ¬FP·¨ÊÇÒ»¸ö¶ÀÌصķ½·¨£¬ÓÉÓڸ÷½·¨²»Ðè·ÖÀëÓÎÀëºÍ½áºÏµÄʾ×ÙÎ¶øÇÒËùÓвⶨÔÚÈÜÒºÖнøÐУ¬¿ÉÒÔ´ïµ½ÕæÕýµÄƽºâ£¬Òò¶ø¾ßÓпìËÙ¡¢¼òµ¥ºÍ׼ȷµÈÌصã¡£ÎÒÃÇÔÚ¹úÄÚÍâÊ״ν«FP¼¼ÊõÓ¦ÓÃÓÚ¶àÖÖ²¡Ô­Î¢ÉúÎï¼ø±ð¡¢·ÖÐͼ°ÄÍÒ©Í»±äÁÙ´²¼ì²âÁìÓò£¬½¨Á¢ÁË»ùÓÚFP¼¼ÊõµÄÈËÈéÍ·Áö²¡¶¾·ÖÐÍ¡¢µ¥´¿ðåÕ¶¾·ÖÐÍ¡¢CTS¡¢URA¡¢NG¡¢MP¡¢CP¡¢ÒҸβ¡¶¾¡¢ÓÄÃÅÂÝÐý¸Ë¾ú¡¢½áºË·ÖÖ¦¸Ë¾úµÈ²¡Ô­Î¢ÉúÎïÄÍÒ©Ïà¹ØÈȵãÍ»±ä·ÖÎöϵͳ¡£ÁÙ´²ÑéÖ¤½á¹û±íÃ÷£¬Ëù½¨Á¢µÄ·ÖÎö·½·¨£¬¾ßÓнá¹û׼ȷºÍ¼ò±ãÒ×ÐеÈÌص㣬ÊÊÓÃÓÚ¶ÔÁÙ´²Ñù±¾½øÐпìËÙ¸ßͨÁ¿É¸²é£»ÒÔFP¼¼ÊõΪ»ù´¡£¬¿ª·¢³öÈËÈéÍ·Áö²¡¶¾·ÖÐÍ¡¢CTS¡¢URA¡¢NG¡¢MP¡¢CP¡¢ÒҸβ¡¶¾¡¢ÓÄÃÅÂÝÐý¸Ë¾ú¡¢½áºË·ÖÖ¦¸Ë¾úÓ«¹âÆ«Õñ¼ì²âÊÔ¼ÁºÐ¡£²ÎÓëÍê³ÉÁË¡¶½âëåëåÔ­Ìå¡¢ÈËÈéÍ·Áö²¡¶¾¡¢É³ÑÛÒÂÔ­Ì忹Ìåµ°°×оƬ¼ì²âϵͳ¡·ºÍ¡¶ÓÄÃÅÂݸ˾ú¿¹Ìåµ°°×оƬ¼ì²âϵͳ¡·µÄÑÐÖÆ¿ª·¢¹¤×÷£¬ÉÏÊöÁ½¸öÏîÄ¿¾ù»ñµÃ¹ú¼ÒÒ»ÀàÐÂÒ©Ö¤Ê飻

2.Ö×ÁöÔ¤¾¯¡¢ÄÍÒ©Ïà¹Ø»ùÒò¡¢SNP¼°¼×»ù»¯µÄ¼ì²âÓëÁÙ´²Ó¦ÓÃÑо¿£ºÈºÌåÖиöÌåµÄ±íÐÍ£¨ÐÎ̬¡¢´úлºÍÃâÒß״̬µÈ£©£¬¸öÌå¶Ô»·¾³Ö²¡ÒòËصÄÒ׸ÐÐÔ¡¢µÖ¿¹Á¦²îÒìÏÔÖø£¬ÕâÖÖ²îÒìµÄÒÅ´«»ù´¡¾ÍÊÇ»ùÒò×é½á¹¹»ò»ùÒòÐͲîÒì¡£SNP¡¢»ùÒòÐͼ°¼×»ù»¯Äܳä·ÖµØ·´Ó³¸öÌå¼äµÄÒÅ´«²îÒ졣ͨ¹ýÑо¿Ê¶±ðÕâЩ»ùÒò£¬È·¶¨¼²²¡Ïà¹Ø»ùÒò£¬¿ÉÒÔ¼ÓÉî¶Ô¼²²¡µÄÈÏʶ£¬¸Ä½ø¼²²¡µÄÕï¶Ï¼°Ô¤·À¡£ÔÚÀûÓÃÒ©Îï½øÐм²²¡ÖÎÁÆʱ£¬²»Í¬²¡È˵ÄÖÎÁÆЧ¹ûÓÐʱ²îÒìÏÔÖø¡£ÕâÖÖ²îÒìÊÇÓÉÒ©Îï±¾ÉíÔÚ²»Í¬¸öÌåÌåÄڻ¡¢´úл¡¢Çå³ý·½ÃæµÄ²îÒìËù¾ö¶¨µÄ£¬ÕâÖÖ²îÒì±¾ÖÊÊÇÒÅ´«²îÒì¡£Ñо¿ÒÅ´«ÒòËضÔÒ©Îï×÷ÓõÄÓ°ÏìºÍ²»Í¬»ùÒòÐ͸öÌå¶ÔÒ©Îï·´Ó¦£ºÒ©ÎïÃô¸ÐÐÔ»òÄÍÊÜÐԵĵIJîÒ죬¿ÉÒÔ²ûÃ÷ÒÅ´«ÒòËضÔÒ©ÎïЧÓõÄÓ°Ï죬´Ó¶øÑ°ÕÒ´øÀ´ÐÂÖÎÁÆ·½°¸µÄ°ÐÏò»ùÒò£¬Ô¤²â·¢ÏÖÓÐÖÎÁÆЧ¹ûµÄ»ùÒò¡£¶ÔÒ©Î￪·¢Ìṩָµ¼ºÍÒÀ¾Ý£¬ÎªÁÙ´²Õë¶ÔÐԵغÏÀíÓÃÒ©ºÍ¸ù¾Ý²»Í¬»ùÒòÐͶÔÒ©ÎïµÄ·´Ó¦À´¸Ä½øÒ©ÎïÉè¼ÆÌṩÀíÂÛÒÀ¾Ý¡£ÎÒÃÇÔÚÓ«¹âÆ«Õñ¼ì²â¼¼Êõƽ̨É϶ԶàÖÖÖ×Áö»¯ÁÆÒ©Îï½øÐÐÁËÏà¹ØSNPµÄÑо¿£¬È¡µÃ³õ²½½øÕ¹£¬²¢»ñµÃ¶àÏî¹ú¼Ò¸ß¼¼Êõ·¢Õ¹¼Æ»®£¨863¼Æ»®£©¼°¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðµÄ×ÊÖú¡£

3£®²¡¶¾¸ÐȾµÄ¶¨ÏòÃâÒßÖÎÁÆÑо¿£ºÎÒ¹úÈËÈéÍ·Áö²¡¶¾HPVËùÖ¼²²¡·¢²¡ÂʽüÄêÓÐËùÔö¸ß¡£¿ÕÅÝÑùÔöÉúÊÇ×î³£¼ûµÄÓÉÈËÈéÍ·Áö²¡¶¾¸ÐȾËùÖµÄÁ¼ÐÔƤ·ôճĤÔöÉú¡£Íç¹ÌÄÑÖΡ¢·´¸´¸´·¢ÐÍÓë°©Ö¢¼°ÆäËüϸ¾ú¡¢²¡¶¾ÌرðÊÇ°®×̲¡Ïà¹Ø£¬Òò´Ë£¬¶ÔÈËÌåÓиü³¤ÆÚ¼°ÑÏÖصÄÓ°Ïì¡£¿ÕÅÝÑùÔöÉúµÄ¸´·¢ÊÇÁÙ´²±È½Ï³£¼ûÇÒ½ÏÄÑ´¦ÀíµÄÎÊÌ⡣Ŀǰ³£ÓõÄÊÖÊõ¼¤¹â¡¢À䶳»ò±£ÊØÖÎÁÆ£º´ó¼ÁÁ¿¸ÉÈÅËؼ¡×¢¼°Ó¦Óÿ¹²¡¶¾Ò©ÎÍâÍ¿Ò©ÎïµÈÖÎÁÆ·½·¨£¬¸´·¢Âʽϸß¡£´Ó1998ÄêÆð£¬ÎÒÃÇÑо¿Á˶ÔÄÑÖÎÐÔ¸´·¢µÄ¿ÕÅÝÑùÔöÉú»¼ÕßÓÃHPV²¡¶¾¿¹Ô­ëijå»÷µÄÊ÷ͻϸ°ûÖÎÁÆ£¬È¡µÃÂúÒâÁÆЧ¡£

4£®¸ºÔð¹ú¼Ò¸ß¼¼ÊõÑо¿·¢Õ¹¼Æ»®£¨863£©ÉúÎïºÍÒ½Ò©¼¼ÊõÁìÓòרÌâ¿ÎÌâ1Ï¸ºÔð¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏ¿ÎÌâ1Ï²Î¼Ó¹ú¼ÒʮһÎ崫Ⱦ²¡ÖØ´óרÏÏî¡¢¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð¿ÎÌ⣲Ïȫ¾üÖØ´óÀ©ÊÔÏîÄ¿£±Ïʡ¼¶»ù½ð¿ÎÌ⣴Ïî¡¢ºáÏò¿ÎÌ⣱Ïî¡£

Ö÷ÒªÏà¹ØÎÄÕ¼°×¨Öø£º

1).Zhang Ju*, Gao Yane, Li Ding, et al. 2009. Asymmetric GP5+/6+ PCR and hybridization with fluorescence polarization assay of 15 human papillomavirus genotypes in clinical samples. J Clin Virol. 44(1):106-110.

2).Bao T, Chen R, Zhang Ju*, et al. 2010. Simultaneousdetection of Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma genitalium and Mycoplasma hominis by fluorescence polarization. J Biotechnol. 150(1):41-3.

3).Wu Zhongliang, Li Ding, Zhang Ju*, et al. 2010. Simultaneous Detection of Four Major Human Herpesviruses in Whole Blood by Fluorescence Polarization Assay. Int J Infect Dis. 14(10):e893-7.

4).Liu Wenchao, Li Xiaoui, Zhang Ju *, et al. 2010. Detection of ERCC1 118 Polymorphisms in Non-small-cell Lung Cancer by an Improved FP Assay. Diagn Mol Pathol. 19(3):164-8.

5).Wu Zhongliang, Zhang Ju*, Liang Ping, et al. 2010. O6-Methylguanine-DNA Methyltransferase Gene Promoter Methylation Detection in Glioma Tumors by a Novel Fluorescence Polarization Assay. Diagn Mol Pathol. 19(4):232-5.

6).Li Ding, Zhang Ju*, Liang Ping, et al. 2010. Detection of single nuclear polymorphisms of XPD in whole blood by fluorescence polarization assay. Chin J Anal Chem. 38(4):458-10.

7).Ding L, Rui C, Zhang Ju*, et al. 2010. Detection of hepatitis B virus genotypes A to D by the fluorescence polarization assay based on asymmetric PCR. J Virol Methods. 168(1-2):31-7.

8£©Ju Z, Yane G, Ding L, Guowu Y, Yanhai G, Yonglan L. Asymmetric GP5+/6+ PCR and hybridization with fluorescence polarization assay of 15 human papillomavirus genotypes in clinical samples.J Clin Virol. 2009;44(2):106-10.

9)£®Ju Zhang, Zhongcan Chen, Yane Gao. A novel fluorescence polarization based assay for 14 human papillomavirus genotypes in clinical samples. J Virol Meth,2006£¬134 (2006) 223¨C229
10£©.ZHANG Ju£¬YAN Xiaojun, SUN Jianzhong£¬et al. A high throughout assay for human papillomavirus genotypes with fluorescence polarization. Chin Med J,2003,116(8):1137-1140.

11).GAO Yan-E, ZHANG JuµÈ. Application of TDI-FP for Analysis of A647G Variation in HPV 16 E7 Gene from Cervical Cancer Patients.ÉúÎﻯѧÓëÉúÎïÎïÀí½øÕ¹£¬2005,32(12):1199-1203

12). GAO Yan-E, ZHANG JuµÈ.Detection and genotyping of human papillomavirus DNA in cervical cancer tissues with fluorescence polarization. Acta Biochimica Et Biophysica Sinica.2003;35(11):1029-1034.

13).GAO Yan-e, ZHANG Ju, SONG Tian-bao, et al. Cloning of HPV16 E2 gene from a cervical cancer biopsy. Reproduction & Contraception,2002,13(3):146-151.

14).³ÂÖвÓ£¬ÕžÕ£¬¸ßÑÞ¶ðµÈ¡£Ó«¹âÆ«Õñ·½·¨¿ìËÙ¼ì²âHPVE7µÚ29λÃÜÂë×ÓµãÍ»±ä, µÚËľüÒ½´óѧѧ±¨,2004,25(15):1403-1406.

15).ÏÄÁÕ£¬ÕžÕ£¬³ÂÖвӵÈ¡£¹¬¾±°©ÓëHLAµÈλ»ùÒòDQB1*03¡¢DR15µÄÏà¹ØÐÔÑо¿£¬µÚËľüÒ½´óѧѧ±¨,2004,25£¨24£©£º2264-2266.

16).ÕžÕ£¬³ÂÖвÓ£¬¸ßÑÞ¶ðµÈ¡£¸ßΣÈËÈéÍ·Áö²¡¶¾58ÐÍE6»ùÒòµÄ¿Ë¡¼°±í´ï£¬µÚËľüÒ½´óѧѧ±¨,2004(3):201-203.

17).³ÂÖвÓ£¬ÕžÕ£¬ãÆС¾ý¡£¸ßΣÈËÈéÍ·Áö²¡¶¾»ùÒò±äÒìÓëÖ°©ÐԵĹØϵÑо¿½øÕ¹£¬¹úÍâҽѧÁÙ´²ÉúÎﻯѧÓë¼ìÑéѧ·Ö²á,2004,25(1):59-61.

18)£®¸ßÑÞ¶ð, ÕžÕ, ³ÂÖвӵÈ¡£¹¬¾±°©×éÖ¯HPV58µÄ¼ì²â¼°ÆäE7»ùÒòµÄ¿Ë¡ºÍ±í´ï,ÖлªÖ×ÁöÔÓÖ¾, 2004,26(9):543-546.

19)£®ÏÄÁÕ,ÕžÕ,°×Óñ½ÜµÈ¡£HLA¡¢HPV±äÒìÓ빬¾±°©Ïà¹ØÐÔÑо¿½øÕ¹,¹úÍâҽѧ¸¾²ú¿Æѧ·Ö²á,2005,32(1)45-47.

20)£®ÕžÕ£¬¸ßÑÞ¶ð£¬ãÆС¾ý¡£Ó«¹âÆ«Õñ¼¼ÊõÔÚµ¥ºËÜÕËá¶à̬ÐÔ¼°»ùÒòÐͼì²âÖеÄÓ¦Ó㬹úÍâҽѧÁÙ´²ÉúÎﻯѧÓë¼ìÑéѧ·Ö²á,2003,24(1):31-33.

21).ÕžÕ£¬¸ßÑÞ¶ð£¬ãÆС¾ý¡£ÈËÈéÍ·Áö²¡¶¾¸ÐȾµÄ¸ßͨÁ¿·ÖÐͼì²âÑо¿½øÕ¹£¬¹úÍâҽѧÁÙ´²ÉúÎﻯѧÓë¼ìÑéѧ·Ö²á,2003,24(2):13-15.

22)£®ÕžÕ£¬¸ßÑÞ¶ð£¬ãÆС¾ý¡£ÈËÈéÍ·Áö²¡¶¾¼ì²âÔÚÔ¤¾¯¼°É¸²é¹¬¾±°©ÖеÄÑо¿, ¹úÍâҽѧ¸¾²ú¿Æѧ·Ö²á,2003,30(5)319-322.

23).³ÂÖÐ²Ó ÕÅ¾Õ Ñ¦ÏþƼµÈ¡£¹¬¾±°©»¼ÕßÈËÈéÍ·Áö²¡¶¾16ÐÍE7»ùÒòµÄ¿Ë¡¼°¼ø¶¨, Ö×Áö·ÀÖÎÔÓÖ¾ 2003,10(Suppl):11-13.

24).ÕžÕ£¬¹ùê̺££¬³ÌºçµÈ¡£pLXSN-HPVL2-Angiostatin µÄ¹¹½¨¼°×ªÈ¾Tϸ°ûÁÜ°ÍÁöϸ°ûϵµÄÌåÍâɱÉË»îÐÔÑо¿£¬ÖйúƤ·ôÐÔ²¡Ñ§ÔÓÖ¾£¬2003,17(6)366-368.

25).ÕžÕ£¬¸ßÑÞ¶ð£¬ãÆС¾ý¡£ÈËÈéÍ·Áö²¡¶¾·ÖÐÍ»ùÒòÕï¶ÏTDI-FP·½·¨Ñо¿ Öлª¼ìÑéҽѧÔÓÖ¾£¬2003,26(3):145-148¡£

26).¸ßÑÞ¶ð£¬ÕžÕ£¬³ÂÖвӵÈ¡£¹¬¾±°©»¼ÕßÈËÈéÍ·Áö²¡¶¾16ÐÍE6»ùÒòµÄ¿Ë¡¼°ÐòÁзÖÎö.Î÷°²½»Í¨´óѧѧ±¨(ҽѧ°æ),2003,24(1):17-19¡£

27)£®¸ßÑÞ¶ð,ÕžÕ,ËÕÕñÐ˵È¡£¼âÈñʪð໼ÕßÈËÈéÍ·Áö²¡¶¾11ÐÍL1»ùÒòµÄ¿Ë¡¼°ÐòÁзÖÎö,ÖйúƤ·ôÐÔ²¡Ñ§ÔÓÖ¾, 2003,17(1):4-6.

28)£®ÕžÕ£¬ãÆС¾ý£¬¸ßÑÞ¶ðµÈ¡£½¨Á¢ÈËÈéÍ·Áö²¡¶¾6£¬11 Ð͸ÐȾƤËðÒÆֲģÐ͵ÄÑо¿£¬ÖйúƤ·ôÐÔ²¡Ñ§ÔÓÖ¾, 2002,16(5):311-313.

29)£®ÕžÕ£¬ãÆС¾ý£¬³ÌºçµÈ¡£¿¹Ô­ëijå»÷AngiostatinÐÞÊÎÁÜ°Íϸ°û¶ÔSihaϸ°ûµÄÌåÄÚÍâ×÷Ó㬠ÖйúÖ×ÁöÉúÎïÖÎÁÆÔÓÖ¾,2002,9(2):96-97.

30)£®ÕžÕ£¬ãÆС¾ý£¬Òü¹úÎäµÈ¡£L1¿¹Ô­³å»÷µÄÊ÷ͻϸ°ûÖÎÁƼâÈñʪðàµÄ³õ²½Ñо¿£¬ÊµÓÃҽѧÔÓÖ¾£¬2002,18(2):129-131.

31)£®ÕžÕ£¬ãÆС¾ý£¬³ÂÞ¨µÈ¡£HPV6ÍíÆÚ±í´ï»ùÒòL1µÄ¿Ë¡²¢ÔÚ¸Ë×´²¡¶¾±í´ïϵͳµÄ±í´ï¼°Æ俹ѪÇåÖƱ¸£¬ÏÖ´úҽѧ¼ìÑ飬2002,17(1):1-3.

32)£®³ÂÞ¨£¬ÕžÕ£¬ãÆС¾ýµÈ¡£ÈËÈéÍ·Áö²¡¶¾16ÐÍÖ÷ÒªÒ¿ǵ°°×L1»ùÒòµÄ¿Ë¡¼°ÐòÁзÖÎö£¬ µÚËľüÒ½´óѧѧ±¨£¬2002,23(7):593-595.

33)£®ÕžÕ£¬ºî褣¬ËÕÕñÐ˵È¡£ÃâÒß½ðÉøÂË·¨¼ì²âÈËÈéÍ·Áö²¡¶¾¿¹ÌåIgG£¬ ÏÖ´ú¼ìÑéҽѧÔÓÖ¾£¬2002, 17(2):41-42.

34)£®¸ßÑÞ¶ð,ÕžÕ.ÈËÈéÍ·Áö²¡¶¾Ïà¹Ø¿¹ÌåµÄ¼ì²â¼°ÒâÒå,¹úÍâҽѧ²¡¶¾Ñ§·Ö²á,2002,9(6):161-165.

35)£®ZHANG Ju, YAN Xiao-Jun, CHEN Zhong-Can, et al. Therapeutic effect of dendritic cells pulsed by L2 peptide on recurrent condyloma acuminata. J Fourth Mil Med Univ£¬2001,22(8):673-678.

36)£®ÕžÕ£¬ãÆС¾ý£¬²ÜÔÆеÈ¡£Ö÷¶¯ÃâÒßÖÎÁƸ´·¢ÐÍÈËÈéÍ·Áö²¡¶¾¸ÐȾ£¬µÚËľüÒ½´óѧѧ±¨, 2001,22 (2):141-144.

37)£®ÕžÕ£¬ãÆС¾ý£¬¶Î½ÜµÈ¡£¿¹Ô­ëijå»÷Ê÷ͻϸ°ûÖÎÁƼâÈñʪðàµÄ²¡Àíѧ¸Ä±ä,ÖйúƤ·ôÐÔ²¡Ñ§ÔÓÖ¾,2001,15(3):180-182.

·¢Ã÷רÀû:

1).Ò»ÖÖÊÊÓÃÓÚÓ«¹âÆ«Õñ¼¼ÊõÖмì²âµ¥ºËÜÕËá¶à̬ÐԵķ½·¨(200910022267.X).

2).Ò»ÖÖÊÊÓÃÓÚÓ«¹âÆ«Õñ¼¼ÊõÖмì²â»ùÒò¼×»ù»¯×´Ì¬µÄ·½·¨(200910024046.X).